Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2019
Price : $35 *
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ataxia telangiectasia
- Focus Registrational; Therapeutic Use
- Acronyms ATTEST
- Sponsors EryDel
- 06 Dec 2018 Planned End Date changed from 1 Mar 2019 to 30 Jun 2020.
- 06 Dec 2018 Planned primary completion date changed from 1 Aug 2018 to 31 Dec 2019.
- 26 Dec 2017 This trial was suspended in Spain, according to European Clinical Trials Database.